Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6835
Source ID: NCT01386671
Associated Drug: Metformin Glycinate
Title: Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
Acronym: COMET
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Metformin glycinate|DRUG: Metformin hydrochloride
Outcome Measures: Primary: Glycosylated hemoglobin (HbA1c), HbA1c: Measured by electrophoresis of lacked total blood using Paragon system and Appraise reader 44800 (Beckman Instruments de Mexico). Fasting Glucose: in serum using glucose oxidase technique with BM/Hitachi 704/911 automated analyzer, 12 months | Secondary: Fasting glucose, 12 months|Total cholesterol, 12 months|High-density lipoprotein (HDL), 12 months|Low-density lipoprotein (LDL), 12 months|Triglycerides, 12 months|Tumor necrosis factor-alpha (TNF-α), 12 months|Adiponectin, 12 months|Resistin, 12 months|Interleukin-1 beta (IL-1β), 12 months|Number of Adverse Events as a Measure of Safety and Tolerability, 12 months|Malonylaldehyde, 12 months|Dismutase superoxide, 12 months
Sponsor/Collaborators: Sponsor: Laboratorios Silanes S.A. de C.V.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 203
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2014-06
Completion Date: 2018-01
Results First Posted:
Last Update Posted: 2018-01-30
Locations: Unidad Antidiabética Integral, Mexico City, AA, 06600, Mexico|Paracelsus S.A. de C.V., Mexico, city, AA, 03800, Mexico|Unidad de Investigacion en Epidemiologia Clinica. UMAE Hospital de Especialidades Centro Medico Nacional Siglo XXI. Instituto Mexicano del Seguro Social, Mexico City, Distrito Federal, 06720, Mexico|Instituto de terapéutica experimental y clínica (INTEC), Guadalajara, Jalisco, 44600, Mexico
URL: https://clinicaltrials.gov/show/NCT01386671